What is Pfizer's orgovyx — revenues:?

Pfizer (PFE) reported orgovyx — revenues: of $109.00M in Q1 2026.

How has Pfizer's orgovyx — revenues: changed year-over-year?

Pfizer's orgovyx — revenues: increased by 43.4% year-over-year, from $76.00M to $109.00M.

Orgovyx — Revenues:

Pfizer Orgovyx — Revenues: decreased by 19.9% to $109.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.4%, from $76.00M to $109.00M.

Analysis

StatementSegment

First reportedQ1 2023

Last reportedQ1 2026May 5, 2026

Rolls up toTotal Revenue

Metric ID: pfe_segment_orgovyx_revenues

Historical Data

11 periods

	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$30.00M	$30.00M	$30.00M	$30.00M	$57.00M	$65.00M	$76.00M	$97.00M	$112.00M	$136.00M	$109.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+90.0%	+14.0%	+16.9%	+27.6%	+15.5%	+21.4%	-19.9%
YoY Change	—	—	—	—	+90.0%	+116.7%	—	—	+96.5%	+109.2%	+43.4%

Range$30.00M – $136.00M

CAGR+67.5%

Avg YoY Growth+91.2%

Median YoY Growth+96.5%

Frequently Asked Questions

What is Pfizer's orgovyx — revenues:?: Pfizer (PFE) reported orgovyx — revenues: of $109.00M in Q1 2026.
How has Pfizer's orgovyx — revenues: changed year-over-year?: Pfizer's orgovyx — revenues: increased by 43.4% year-over-year, from $76.00M to $109.00M.